Investitionsthese
MVM invests in innovative healthcare businesses addressing unmet needs in large markets. Its healthcare investment focus spans medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and related sectors.
Investitionsphase
Growth-stage companies (investments typically $20M–$100M, with flexibility for larger investments in select cases).
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Healthcare, including medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, and digital health
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€20.000.000 - €100.000.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (21)
A
Addison Van Emon
Team Member
A
Arantza Rodriguez
Team Member
C
Chris Murray
Partner
C
Conrad Crans
Team Member
E
Eric Bednarski
Managing Partner
E
Eric Fritz
Investment Team Member
H
Hugo Harrod
Partner
I
Isabella Mihov
Team Member
J
Jack Tanaka
Partner
K
Kevin Cheng
Investment Professional
K
Kyle Dempsey
Team Member
L
Liz Butler
Team Member
M
Matthew McPherron
Key Employee
N
Neil Akhurst
Partner
O
Orlanda Bryars
Team Member
S
Shalima Raza
Team Member
S
Stephen Reeders
Founder
T
Talia Kirschbaum
Team Member
T
Thangam Jayaram
Partner
T
Thomas Casdagli
Partner
V
Valentin Buerki
Key Employee